| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |